Liantao Li

3.9k citations
115 papers · 2.9k indexed · 1 hit paper · h-index 27
  • Oncology top 5%
    • CAR-T cell therapy research 21
    • Cancer Immunotherapy and Biomarkers 6
  • Immunology top 5%
    • Immunotherapy and Immune Responses 8
    • Immune Cell Function and Interaction 6
    • Cancer, Hypoxia, and Metabolism 7
    • Epigenetics and DNA Methylation 7
    • RNA Interference and Gene Delivery 5
  • Nephrology top 10%
    • Virus-based gene therapy research 16

Liantao Li

110 papers receiving 2.9k citations

Hit Papers

Ki67 is a promising molecular target in the diagnosis of ...6062014202620182022200400600

Peers

Liantao Li
Comparison fields: 5 of 140
  • Oncology 869
  • Immunology 567
  • Cancer Research 368
  • Molecular Biology 1.2k
  • Nephrology 78
Replace Hideyuki Yamawaki with:
Hideyuki Yamawaki Japan
Li Kong China
Jing Xiao China
Wenbin Li China
Min Hu China
Zheng Wang China
Arianna Gonelli Italy
Peng Zhao China
Amar B. Singh United States
Liantao Li relative to Hideyuki Yamawaki Japan Hideyuki Yamawaki's profile →
Citations per field
00.5×1.5×
Hideyuki Yamawaki · 1×
Citations per year

Countries citing papers authored by Liantao Li

Since Specialization
Citations

This map shows the geographic impact of Liantao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liantao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liantao Li more than expected).

Fields of papers citing papers by Liantao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liantao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liantao Li. The network helps show where Liantao Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Liantao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liantao Li Line = papers co-authored together Liantao Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20240
3 20242
4 20241
5 20246
6 201917
7 20195
8 201729
9 20168
10 20151
11 201415
12 201417
13 201316
14 201213
15 201216
16 201115
17 201131
18 200833
19 200618
20 200629

About Liantao Li

Liantao Li is a scholar working on Oncology, Immunology and Cancer Research, having authored 115 papers that have together received 2.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Virus-based gene therapy research (16 papers), Immunotherapy and Immune Responses (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Oncology (869 citations), Immunology (567 citations) and Cancer Research (368 citations). Liantao Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guan Jiang, Jun Zheng, Qian Chen, Junnian Zheng, Huizhong Li, Junnian Zheng, Junping Wen, Qing Zhang, Gang Chen and Baofu Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026